BPC-157

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence in human gastric juice, marketed for tendon, ligament, and gut healing. Animal studies suggest pro-angiogenic and tissue-repair effects, but human clinical-trial data are very limited, comprising only a small number of pilot studies with no large well-controlled RCTs. It is not approved by the FDA or EMA, has been added to FDA restriction lists, and is prohibited at all times under WADA category S0 (Unapproved Substances), as it has not been approved by any governmental health authority for human therapeutic use.